U.S. Markets closed

Merck & Co., Inc. (MRK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
64.92-0.12 (-0.18%)
At close: 4:02PM EDT
People also watch
PFEJNJBMYLLYPG
Interactive chart
Previous Close65.04
Open65.00
Bid64.64 x 200
Ask65.16 x 200
Day's Range64.82 - 65.21
52 Week Range55.10 - 66.80
Volume3,685,720
Avg. Volume8,939,996
Market Cap177.57B
Beta0.95
PE Ratio (TTM)41.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.88 (2.89%)
Ex-Dividend Date2017-03-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.19 hours ago

    Top Presentations to Look for at ASCO

    The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be presented ...

  • Zacks2 days ago

    Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others

    Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others

  • American City Business Journals2 days ago

    ​Cambridge biotech Enumeral faces uncertain future as cash dries up

    Cambridge cancer drug developer Enumeral could be forced to downsize, file for bankruptcy or sell its assets unless it quickly raises additional capital, the company said this week. Amid the cash crunch, Enumeral said it is “exploring a range of potential transactions.” According to the company, that could include a public or private offering, debt financing, collaborations and licensing deals, or a potential merger or asset sale. A representative for Enumeral did not immediately respond to an interview request on Friday.